¨
B. Yucel et al. / Tetrahedron 61 (2005) 11355–11373
11368
(Cquat), 139.48 (Cquat), 149.94 (Cquat, C]O), 152.08 (Cquat
,
58.66 (C, cychex), 66.79 (K, CH2OCH2), 125.46 (C,
Ph-C), 127.66 (C, Ph-C), 127.85 (Cquat), 128.62 (C, Ph-C),
131.36 (Cquat), 133.92 (Cquat), 149.51 (Cquat, C]O), 151.98
(Cquat, C]O); MS (70 eV, EI), m/z (%): 422 (54) [MC], 393
(16), 337 (22), 336 (100), 217 (16), 114 (14), 100 (42);
elemental analysis calcd (%) for C24H30N4O3 (422.5): C
68.22, H 7.16; found: C 67.91, H 7.07.
C]O); MS (70 eV, EI), m/z (%): 450 (27) [MC], 364 (100)
[MCKmorpholine], 348 (8), 173 (17), 114 (30), 100 (90);
elemental analysis calcd (%) for C24H26N4O3S (450.6): C
63.98, H 5.82, N 12.43; found: C 63.76, H 5.71, N 12.68.
Diastereomer II. Mp 122 8C, RfZ0.15 (light petroleum/
ethyl acetate 3:1); IR (KBr): n~Z3108, 3062, 2963, 2858,
1
2796, 1775, 1714, 1502, 1411, 1112, 766, 713 cmK1; H
Minor diastereomer. RfZ0.108 (light petroleum/ethyl
acetate 3:1); IR (KBr): n~Z3071, 2932, 2853, 1772, 1714,
1546, 1504, 1413, 1295, 1264, 1130, 1117, 1029, 985,
766 cmK1;1H NMR (300 MHz, CDCl3): dZ0.60–0.67 (m,
1H, cPr-H), 0.70–0.77 (m, 1H, cPr-H), 0.82–0.89 (m, 1H,
cPr-H), 0.99–1.06 (m, 1H, cPr-H), 1.13–1.29 (m, 1H,
cychex), 1.36 (d, JZ6.3 Hz, 3H, CH3), 1.46 (td, JZ3.2,
12.0 Hz, 1H, cychex), 1.57 (tt, JZ3.5, 13.0 Hz, 1H,
cychex), 1.71 (td, JZ3.5, 13.7 Hz, 1H, cychex), 1.82–1.86
(m, 2H, cychex), 2.56 (t, JZ4.6 Hz, 4H, CH2NCH2), 2.98–
3.03 (m, 1H, cychex), 3.25 (d, JZ13.60 Hz, 1H, cychex),
3.58 (q, JZ3.9 Hz, 4H, CH2OCH2), 4.17 (dd, JZ4.1,
11.2 Hz, cychex), 4.67 (q, JZ6.3 Hz, 1H, 1-H), 7.29–7.34
(m, 1H, Ph), 7.46–7.51 (m, 4H, Ph); 13C NMR
(75.478 MHz, CDCl3, DEPT): dZ11.25 (K, cPr-C),
13.51 (K, cPr-C), 19.87 (C, CH3), 23.83 (K, cychex),
27.25 (K, cychex), 30.26 (K, cychex), 34.44 (K, cychex),
44.07 (Cquat, cPr-C), 49.66 (K, CH2NCH2), 51.37 (C, C-1),
58.39 (C, cychex), 67.30 (K, CH2OCH2), 125.37 (C,
Ph-C), 126.99 (Cquat), 127.80 (C, Ph-C), 128.95 (C, Ph-C),
131.33 (Cquat), 136.57 (Cquat), 149.67 (Cquat, C]O), 152.78
(Cquat, C]O); MS (70 eV, EI), m/z (%): 422 (79) [MC], 407
(11) [MCKCH3], 336 (55), 261 (18), 247 (30), 246 (100),
232 (27), 218 (24), 178 (20), 119 (39), 91 (42), 77 (20), 41
(22) for C24H30N4O3 (422.53); HRMS(EI):calcd 422.2318
(correct HRMS).
NMR (250 MHz, CDCl3): dZ1.17–1.44 (m, 3H, cPr-H),
1.25 (d, JZ6.4 Hz, 3H, CH3), 2.32 (q, JZ6.4 Hz, 1H, 1-H),
2.47 (br s, 4H, cPr-H, CH2NCH2), 2.81–2.90 (m, 1H, cPr-
H), 3.69 (t, JZ4.5 Hz, 4H, CH2OCH2), 5.89 (d, JZ5.0 Hz,
1H, 80-H), 6.29 (d, JZ4.86 Hz, 1H, 70-H), 6.98 (dd, JZ3.5,
5.1 Hz, 1H, thiophene), 7.19 (d, JZ3.4 Hz, 1H, thiophene),
7.27–7.42 (m, 6H, Ph, thiophene); 13C NMR (62.9 MHz,
CDCl3, DEPT): dZ9.37 (K, cPr-C), 11.56 (K, cPr-C),
18.22 (C, CH3), 41.92 (Cquat, cPr-C), 50.76 (K,
CH2NCH2), 53.19 (K, C-80), 58.27 (C, C-1), 67.04 (K,
CH2OCH2), 120.19 (C, C-70), 125.47 (C, Ph), 126.49 (C,
Ph or thiophene), 126.83 (C, thiophene), 127.76 (C,
thiophene), 128.06 (C, Ph or thiophene), 128.91 (C, Ph),
130.75 (Cquat), 138.75 (Cquat), 139.31 (Cquat), 150.45 (Cquat
,
C]O), 152.15 (Cquat, C]O); MS (70 eV, EI), m/z (%): 450
(9) [MC], 363 (32) [MCKmorpholine-H], 348 (4), [MCK
morpholine–H–CH3], 173 (11), 114 (36), 100 (100);
elemental analysis calcd (%) for C24H26N4O3S(450.6): C
63.98, H 5.82; found: C 63.90, H 6.06.
4.3.18. 60-[1-Morpholin-4-ylethyl]-20-phenylspiro[cyclo-
propane-1,50(10a’H)-50,70,80,90,100,10a0-hexahydro-[1,2,
4]triazolo[1,2-a]cinnoline]-1,3-dione (42a). According to
GP-A, Pd(OAc)2 (22.4 mg, 100 mmol), tri-2-furylphosphine
(46.4 mg, 200 mmol), Et3N (202 mg, 2.00 mmol), morpho-
line (12a, 174 mg, 2.00 mmol), 1-iodo-cyclohexene (34,
416 mg, 2.00 mmol) and bicyclopropylidene (1, 320 mg,
4.00 mmol) were stirred in anhydrous DMF (1 mL), at
100 8C for 5 h. N-Phenyltriazolinedione (37, 700 mg,
4.00 mmol) was added to the ice-cooled mixture, and then
it was stirred again at room temperature for 48 h. After
work-up and drying (MgSO4), the solvent was removed in a
rotatory evaporator. The residue was subjected to column
chromatography on silica gel (100 g, 3!30 cm, light
petroleum/ethyl acetate, 3:1) to yield 42a (280 mg, 33%,
colorless solid) as a mixture of two diastereomers (ratio
4.6:1 according to NMR).
4.3.19. 60-[1-Morpholin-4-ylethyl]-90-(N)-benzyl-20-
phenylspiro[cyclopropane-1,50(10a’H)-50,70,80,90,100,
10a0-hexahydro[1,2,4]triazolo[1,2-a]cinnoline]-1,3-dione
(43a). According to GP-B, Pd(OAc)2 (22.4 mg, 100 mmol),
tri-2-furylphosphine (46.4 mg, 200 mmol), K2CO3 (556 mg,
4.00 mmol), Et4NCl (332 mg, 2.00 mmol), morpholine
(12a, 174 mg, 2.00 mmol), 1-benzyl-4-iodo-1,2,3,6-tetra-
hydropyridine (35, 600 mg, 2.00 mmol) and bicyclopropyl-
idene (1, 320 mg, 4.00 mmol) were stirred in anhydrous
MeCN (2 mL), at 80 8C for 3 h. N-Phenyltriazolinedione
(37, 700 mg, 4.00 mmol) was added to the ice-cooled
mixture, and then it was stirred at room temperature for an
additional 48 h. After work-up and drying (MgSO4), the
solvent was removed in a rotatory evaporator. The residue
was subjected to column chromatography on silica gel
(100 g, 3!30 cm, light petroleum/ethyl acetate, 3:1) to
yield 43a (180 mg, 17%, colorless oil), RfZ0.17 (light
petroleum/ethyl acetate 3:1); IR (film): n~Z3028, 2956,
2850, 2798, 1770, 1713, 1503, 1456, 1412, 1361, 1265,
Major diastereomer. Mp 151 8C, RfZ0.446 (light petro-
leum/ethyl acetate, 3:1); IR (KBr): n~Z3033, 2961, 2926,
2856, 1762, 1709, 1504, 1459, 1415, 1301, 1270, 1128,
1
1117, 1069, 1033, 866, 765 cmK1; H NMR (300 MHz,
C2D2Cl4, 100 8C): dZ1.22–1.36 (m, 1H, cPr-H), 1.28 (d,
JZ6.8 Hz, 3H, CH3), 1.37–1.48 (m, 1H, cPr-H), 1.51–1.67
(m, 1H, cychex), 1.75 (dt, JZ3.6, 13.1 Hz, 1H, cychex),
1.88–2.00 (m, 5H, cPr-H, cychex), 2.06–2.14 (m, 1H,
cPr-H), 2.47–2.54 (m, 1H, 1-H), 2.49 (t, JZ4.4 Hz, 4H,
CH2NCH2), 2.65–2.71 (m, 1H, cychex), 3.71 (t, JZ4.7 Hz,
4H, CH2OCH2), 3.77 (br s, 1H, cychex), 4.23 (dd, JZ4.2,
10.8 Hz, 1H, cychex), 7.35–7.52 (m, 5H, Ph); 13C NMR
(75.5 MHz, C2D2Cl4, 100 8C, DEPT): dZ10.03 (K, cPr-C),
10.48 (K, cPr-C), 18.04 (C, CH3), 24.28 (K, cychex),
26.80 (K, cychex), 29.91 (K, cychex), 31.99 (K, cychex),
40.88 (Cquat, cPr-C), 51.88 (K, CH2NCH2), 57.68 (C, C-1),
1120, 1071, 1029, 936, 863, 736, 739 cmK1 1H NMR
;
(300 MHz, C2D2Cl4, 100 8C): dZ1.24–1.33 (m, 1H, cPr-H),
1.29 (d, JZ6.8 Hz, 3H, CH3), 1.36–1.43 (m, 1H, cPr-H),
1.79–1.87 (m, 1H, cPr-H), 2.02–2.15 (m, 2H, tetrahydro-
pyridine), 2.24 (t, JZ10.3 Hz, 1H, tetrahydropyridine),
2.29–2.35 (m, 1H, cPr-H), 2.39–2.51 (m, 1H, 1-H), 2.47 (q,
JZ4.3 Hz, 4H, CH2NCH2), 2.94–2.99 (m, 1H, tetrahydro-
pyridine), 3.56–3.78 (AB system: dAZ3.6, dBZ3.8, JABZ
13.3 Hz, 2H, Bn), 3.56–3.78 (1H, tetrahydropyridine)*, 3.68